-
Product Insights
New![]()
Cf & I Pit Mine
The Cf & I Pit Mine is a iron ore mine in United States. It is currently in operation. Empower your strategies with our Cf & I Pit Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability...
-
Product Insights
New![]()
CFS Alarcos Solar PV Park
CFS Alarcos Solar PV Park is a solar PV project located in Castile-La Mancha, Spain. The project is owned by China Three Gorges Corp and was developed by Innogy SE; Photosolar Medina 4 SL; Synergia Energy Solutions SL; X-ELIO Energy SL. The project came online in 2019. Empower your strategies with our CFS Alarcos Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be...
-
Company Insights
New![]()
Innovation and Patenting activity of CF Industries Holdings Inc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of CF Industries Holdings Inc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
![]()
CF Industries Port Neal Complex, United States
Each petrochemical complex profile includes core details such as complex name, location, complex status, start year, annual petrochemical capacity (mtpa) for the period 2015-2030, key feedstock, key products produced, operator, technology, key products capacity and capacity share of the total annual capacity of the complex. We also provide contractor details such as EPC/Design & FEED contractors for the petrochemical complex. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day...
-
Product Insights
![]()
CF Industries and Mitsui Ascension Parish Complex, United States
Each petrochemical complex profile includes core details such as complex name, location, complex status, start year, annual petrochemical capacity (mtpa) for the period 2015-2030, key feedstock, key products produced, operator, technology, key products capacity and capacity share of the total annual capacity of the complex. We also provide contractor details such as EPC/Design & FEED contractors for the petrochemical complex. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day...
-
Product Insights
![]()
CF Industries Donaldsonville Complex, United States
CF Industries Donaldsonville Complex is located in Louisiana, United States. The petrochemicals complex is owned by CF Industries Holdings Inc. It is operated by CF Industries Holdings Inc. CF Industries Donaldsonville Complex profile includes core details such as complex name, location, complex status, start year, annual petrochemical capacity (mtpa) for the period 2015-2030, key feedstock, key products produced, operator, technology, key products capacity and capacity share of the total annual capacity of the complex. We also provide contractor details such...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – VAX-31 in Streptococcal Pneumonia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. VAX-31 in Streptococcal Pneumonia Drug Details: VAX-XP is under development for the prevention of streptococcus...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Luveltamab Tazevibulin in Relapsed Acute Myeloid Leukemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Luveltamab Tazevibulin in Relapsed Acute Myeloid Leukemia Drug Details: STRO-002 is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Luveltamab Tazevibulin in Fallopian Tube Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Luveltamab Tazevibulin in Fallopian Tube Cancer Drug Details: STRO-002 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Luveltamab Tazevibulin in Endometrial Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Luveltamab Tazevibulin in Endometrial Cancer Drug Details: STRO-002 is under development for the treatment of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.